KMID : 0377819980180060652
|
|
Diagnosis and Treatment 1998 Volume.18 No. 6 p.652 ~ p.659
|
|
IMPACTS OF ADDED PROGESTOGEN ON BIOCHEMICAL MARKERS OF THE BONE TURNOVER UNDERGOING HORMONE REPLACEMENT THERAPY IN POSTMENOPAUSAL WOMEN
|
|
|
|
Abstract
|
|
|
Purpose To evaluate the impact of added progestogen on biochemical markers of the bone turnover undergoing hormone replacement therapy in the postmenopausal women. Method : There are 71 postmenopausal women who are divided into three groups (Group I, Group II, Group III). Group I(continuous combined) is given conjugated equine estrogen WEE, 0.625mg, day 1-30) plus medroxy-
progesterone acetate (MPA, 2.5mg, day 1-30), Group II(unopposed estrogen) is given conjugated equine estrogen(CEE, 0.625mg, day 1-30) only, Group III(continuous sequence) is given conjugated equine estrogen(CEE, 0. 625mg, day 1-30) plus medroxyprogesterone acetate (MPA, 5mg, day 1-12). And there were measured serum osteocalcin, serum total alkaline phosphatase and urinary deoxypyridinoline excretion before starting hormone replacement therapy and 12 months later. Results : The serum osteocalcin, serum total alkaline phosphatase and urinary deoxypyridinoline excretion significantly decreased after hormone replacement therapy (Group I, II, III). And there was no significance
|
|
KEYWORD
|
|
|
|
FullTexts / Linksout information
|
|
|
|
Listed journal information
|
|
|
|